Source link : https://www.newshealth.biz/health-news/wegovy-heart-benefits-will-help-payer-discussions-novo-nordisk/
COPENHAGEN (Reuters) – Novo Nordisk expects new data showing the heart benefits of its weight-loss drug Wegovy will help its discussions with public health authorities and other payers about the benefits of paying for it, executives said on Thursday. “This is a key piece of evidence when we have payer discussions on a global level […]
Author : News Health
Publish date : 2023-08-11 17:57:21
Copyright for syndicated content belongs to the linked Source.